Neogen reported $217.7M in Ordinary Share Capital for its fiscal quarter ending in March of 2026.





Ordinary Share Capital Change Date
Agilent USD 282.22M 478K Mar/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Danaher USD 702.9M 4.8M Jun/2026
Idexx Laboratories USD 78.87M 366K Jun/2026
Illumina USD 151.3M 607K Jun/2026
Integra LifeSciences USD 77.78M 39K Jun/2026
Neogen USD 217.7M 27K Mar/2026
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quidel USD 68.1M 200K Mar/2026
STAAR Surgical USD 49.78M 377K Mar/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
Utah Medical Products USD 3.18M 2K Mar/2026
Zoetis USD 420.35M 4.58M Mar/2026